Skip to content
All tests

Your test, explained

5 min read

Hepatic Function (Liver) Panel

An advanced 7-biomarker panel measuring hepatic transaminases, biliary flow enzymes, and synthetic proteins to evaluate overall liver structural integrity and metabolic capacity.

At a glance

Price Starting from

$49.00USD

Test price · additional fees may apply

Sample
Blood (Serum)
Typical turnaround
2 - 3 days
Before your appointment

Your options, side by side

Compare retailer prices.

Find a listing that fits your needs. Review the details, then order with the retailer.

1 listing

1 match · USD

New Health Labs

Liver Function Test (LFT)

Listed price $49.00
Fees & listing detailsRecorded Oct 2, 2026
Additional listing fee
$0.00
Blood draw
Not provided
Service
$6.00
Requisition
Not provided

Listed prices exclude any extra charges shown here. Confirm the final total and collection requirements with the retailer.

This observation is older than 7 days.

Prices shown are listed test prices, not checkout totals. Expand a listing for supplied fees and its observation date. Check included measurements, collection requirements, and the performing lab before ordering.

Understand before you decide

The test, explained.

Overview

Your liver is the master biochemical refinery of the human body, performing over 500 critical functions ranging from deep cellular detoxification to macronutrient partitioning and hormone clearance.

The Hepatic Function Panel (HFP) is far more than a simple "damage check" for heavy drinkers. In modern functional medicine, it is a primary diagnostic tool for assessing metabolic flexibility. The enzymes and proteins measured in this panel reveal the early, silent progression of ectopic fat storage in the liver, the efficiency of your biliary (bile) flow, and your liver's capacity to synthesize the transport proteins necessary for a long, healthy lifespan.

About this test

Advanced Clinical Interpretation of the Hepatic Panel

This panel breaks down into three distinct physiological categories: Hepatocellular (liver cell) injury, Cholestatic (biliary/bile duct) flow, and Hepatic Synthetic capacity.

1. Hepatocellular Integrity: The Transaminases (ALT & AST)
  • ALT (Alanine Aminotransferase): This enzyme is primarily localized in the cytosol of liver cells. When liver cells are stressed or inflamed (from sugar, alcohol, viruses, or hepatotoxic supplements), they rupture and leak ALT into the bloodstream. In metabolic optimization, an ALT over 25 U/L for women or 33 U/L for men is a clinical red flag for early-stage liver fat accumulation, regardless of what "normal" lab ranges state.

  • AST (Aspartate Aminotransferase): While present in the liver, AST is also highly concentrated in the mitochondria of skeletal muscle and cardiac tissue. Therefore, isolated high AST without high ALT might indicate intense muscle breakdown from exercise rather than liver disease.

  • The AST/ALT (De Ritis) Ratio: This ratio is a profound diagnostic tool. An AST/ALT ratio > 1.0 (with both elevated) often points to alcohol-induced liver stress or advanced fibrosis. A ratio < 1.0 (where ALT is significantly higher than AST) is the classic biochemical signature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

2. Cholestatic Markers: Biliary Flow (ALP & Bilirubin)
  • Alkaline Phosphatase (ALP): An enzyme concentrated in the bile ducts (and bones). When bile flow becomes sluggish or obstructed (cholestasis)—often due to gallstones or thickened bile—ALP rises. It is a critical marker for gallbladder health and toxin excretion.

  • Bilirubin (Total, Direct, and Indirect): A yellowish pigment created when the spleen breaks down old red blood cells. The liver must "conjugate" (make water-soluble) this pigment to excrete it in bile. Interestingly, mild, chronic elevations of unconjugated (indirect) bilirubin—often diagnosed as benign Gilbert's Syndrome—are now recognized by biohackers as a massive cardiovascular advantage, as bilirubin is one of the most potent endogenous antioxidants in the human body.

3. Synthetic Function: Albumin & Total Protein
  • Albumin: The liver is a protein factory. Albumin is its primary product, acting as a massive cargo ship in your blood. It transports hormones (like testosterone and thyroid hormone), fatty acids, and medications. High-normal Albumin (typically >4.5 g/dL) is a hallmark of robust longevity, adequate amino acid intake, and a highly functioning liver. Low albumin is a lagging indicator of severe liver dysfunction or systemic inflammation.

When to discuss this test

You should prioritize this hepatic evaluation when:

  • You are carrying excess visceral fat (belly fat) and want to determine if you are developing silent "Fatty Liver" (MASLD).
  • You are utilizing Bioidentical Hormone Replacement Therapy (BHRT), Testosterone Replacement Therapy (TRT), or oral peptides, which must pass through hepatic metabolism.
  • You experience symptoms of poor bile flow, such as floating/pale stools, nausea after eating fatty meals, or a yellowish tint to the sclera (whites of the eyes).
  • You are taking long-term prescription medications (like Statins, SSRIs, or Accutane) that carry a risk of drug-induced liver injury (DILI).

Who may benefit

This test is an absolute necessity for biohackers mapping their metabolic flexibility, athletes pushing their physical limits, and anyone seeking to reverse prediabetes, as the liver is the primary organ dictating systemic insulin resistance.

How this test is used

  • Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  • Hepatitis (Viral, Autoimmune, or Toxic)
  • Biliary Obstruction and Gallbladder Dysfunction
  • Gilbert's Syndrome

Before your appointment

Plan your visit.

Fasting
Required · 10 hours
Collection timing
Morning collection preferred

How to prepare

  • Exercise Caution: You MUST abstain from heavy resistance training or intense endurance exercise for at least 48 to 72 hours prior to this test. Intense muscle contractions cause micro-tears that leak AST into the bloodstream, triggering a false-positive for liver damage.
  • Alcohol and Hepatotoxic Agents: Abstain from all alcohol consumption for at least 72 hours prior. Additionally, inform your provider if you are taking oral anabolics, high-dose acetaminophen (Tylenol), or specific herbal supplements (like Kava or high-dose Ashwagandha), as these heavily skew transaminase readings.
  • Fasting is Recommended: While standard labs may say fasting is not strictly required, eating a high-fat meal can cause lipemia (fat in the blood), which interferes with the optical assays used to measure Bilirubin and AST. Fasting for 8-12 hours provides the cleanest clinical baseline.

Important considerations

The Muscle Breakdown Confound: As mentioned, AST is not liver-specific. If your AST is elevated but ALT, ALP, and Bilirubin are perfectly normal, the liver is likely not the issue. The elevation is almost certainly from muscle breakdown. In such cases, a follow-up Creatine Kinase (CK) test should be ordered to confirm muscle origin and prevent an unnecessary liver biopsy or panic.

Follow the instructions from your retailer and clinician. Information on this page is educational and does not replace individual medical advice.

See what to expect

Sample reports & resources.

Published examples and supporting files for this test.

No sample files are published for this test yet.

Looking for your own results? Open your reports dashboard

For a closer look

Sources & further reading.

Further reading

2025–2026 Clinical Breakthroughs:

  • The MASLD Paradigm Shift: As of 2024/2025, the global hepatology community officially abandoned the term "Non-Alcoholic Fatty Liver Disease (NAFLD)" in favor of "Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)." This is not just a name change; it reflects the groundbreaking clinical realization that liver fat accumulation is a primary, active driver of systemic metabolic syndrome, rather than just a passive bystander of obesity.
  • The FIB-4 Score Utility: Advanced longevity clinics in 2025 have widely adopted the FIB-4 index. By plugging the AST and ALT numbers from this exact panel, along with the patient's age and platelet count, algorithms can now predict advanced liver fibrosis with incredible accuracy, completely eliminating the need for invasive liver biopsies in over 70% of early-stage patients.
  • Bilirubin as a Longevity Molecule: 2025 cardiovascular research published in the Journal of Hepatology completely flipped the narrative on Gilbert's Syndrome. Patients with chronically high-normal or slightly elevated unconjugated bilirubin have been proven to have significantly lower rates of coronary artery disease, stroke, and all-cause mortality, reclassifying mild bilirubin elevation from a "disease" to a profound evolutionary advantage against oxidative stress.

Sources